Andrew Leonard Laccetti, Matthew R. Smith, Howard I. Scher, Sepehr Nowfar, David Johnson Einstein, Benjamin Martin, Patrick Adorjan, Manjari Dissanayake, Frank Verholen, Xin Gao. "Efficacy and safety of darolutamide monotherapy in patients with castration-sensitive prostate cancer (CSPC) after biochemical recurrence (BCR): 52-week results from ARAMON.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.167